214 related articles for article (PubMed ID: 37802188)
1. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
Hino-Arinaga T; Ide T; Kuromatsu R; Miyajima I; Ogata K; Kuwahara R; Hisamochi A; Torimura T; Sata M;
J Gastroenterol; 2012 May; 47(5):569-76. PubMed ID: 22187167
[TBL] [Abstract][Full Text] [Related]
3. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series.
Wong RJ; Gish R; Frederick T; Bzowej N; Frenette C
Dig Dis Sci; 2011 Feb; 56(2):578-85. PubMed ID: 21046244
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
Tansel A; Katz LH; El-Serag HB; Thrift AP; Parepally M; Shakhatreh MH; Kanwal F
Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1207-1217.e4. PubMed ID: 28215616
[TBL] [Abstract][Full Text] [Related]
5. Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
Dakhoul L; Jones KR; Gawrieh S; Ghabril M; McShane C; Vuppalanchi R; Vilar-Gomez E; Nephew L; Chalasani N; Lammert C
Dig Dis Sci; 2019 Jun; 64(6):1705-1710. PubMed ID: 30617453
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.
Yeoman AD; Al-Chalabi T; Karani JB; Quaglia A; Devlin J; Mieli-Vergani G; Bomford A; O'Grady JG; Harrison PM; Heneghan MA
Hepatology; 2008 Sep; 48(3):863-70. PubMed ID: 18752332
[TBL] [Abstract][Full Text] [Related]
7. Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis.
Yan LJ; Yao SY; Meng GX; Liu KX; Li HC; Ding ZN; Dong ZR; Hong JG; Chen ZQ; Li T
Hepatol Int; 2021 Dec; 15(6):1413-1420. PubMed ID: 34478116
[TBL] [Abstract][Full Text] [Related]
8. Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.
Sharma R; Verna EC; Simon TG; Söderling J; Hagström H; Green PHR; Ludvigsson JF
Am J Epidemiol; 2022 Jan; 191(2):298-319. PubMed ID: 33913487
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma in patients with autoimmune hepatitis.
Teufel A; Weinmann A; Centner C; Piendl A; Lohse AW; Galle PR; Kanzler S
World J Gastroenterol; 2009 Feb; 15(5):578-82. PubMed ID: 19195059
[TBL] [Abstract][Full Text] [Related]
10. Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
Chang ML; Le PH; Chen WT; Chen TD; Chien RN
Dig Dis Sci; 2024 Jun; 69(6):2193-2203. PubMed ID: 38653947
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.
van Gerven NM; Verwer BJ; Witte BI; van Erpecum KJ; van Buuren HR; Maijers I; Visscher AP; Verschuren EC; van Hoek B; Coenraad MJ; Beuers UH; de Man RA; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Mulder CJ; van Nieuwkerk CM; Bouma G;
Scand J Gastroenterol; 2014 Oct; 49(10):1245-54. PubMed ID: 25123213
[TBL] [Abstract][Full Text] [Related]
12. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
Tsai PC; Kuo HT; Hung CH; Tseng KC; Lai HC; Peng CY; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Kao JH; Liu CJ; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Tai CM; Lin CW; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Yeh ML; Huang CF; Hsieh MH; Huang JF; Dai CY; Chung WL; Chen CY; Yu ML;
J Hepatol; 2023 Feb; 78(2):281-292. PubMed ID: 36208843
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Braga MH; Cançado GGL; Bittencourt PL; Couto CA; Guedes LV; Lima AMC; Ferraz MLG; Villela-Nogueira CA; Nardelli MJ; Faria LC; Gomes NMF; Oliveira EMG; Rotman V; Oliveira MB; da Cunha SMCF; Cunha-Silva M; Mendes LSC; Ivantes CAP; Codes L; de Almeida E Borges VF; Pace FHL; Pessoa MG; Signorelli IV; Coral GP; Filho JG; Chagas AL; Terrabuio DRB; Cançado ELR;
Ann Hepatol; 2023; 28(4):101105. PubMed ID: 37088418
[TBL] [Abstract][Full Text] [Related]
14. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study.
West J; Card TR; Aithal GP; Fleming KM
Aliment Pharmacol Ther; 2017 Apr; 45(7):983-990. PubMed ID: 28144999
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
Reddy KR; McLerran D; Marsh T; Parikh N; Roberts LR; Schwartz M; Nguyen MH; Befeler A; Page-Lester S; Tang R; Srivastava S; Rinaudo JA; Feng Z; Marrero JA
Gastroenterology; 2023 Oct; 165(4):1053-1063.e6. PubMed ID: 37429366
[TBL] [Abstract][Full Text] [Related]
18. Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.
Lee J; Yoo SH; Sohn W; Kim HW; Choi YS; Won JH; Heo JY; Park SJ; Park YM
Clin Mol Hepatol; 2016 Sep; 22(3):339-349. PubMed ID: 27729627
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis--a long-term follow-up study in 634 Swedish patients.
Danielsson Borssén Å; Almer S; Prytz H; Wallerstedt S; Friis-Liby IL; Bergquist A; Nyhlin N; Hultcrantz R; Sangfelt P; Weiland O; Lindgren S; Verbaan H; Werner M
Scand J Gastroenterol; 2015 Feb; 50(2):217-23. PubMed ID: 25483724
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
Papatheodoridis GV; Sypsa V; Dalekos GN; Yurdaydin C; Van Boemmel F; Buti M; Calleja JL; Chi H; Goulis J; Manolakopoulos S; Loglio A; Voulgaris T; Gatselis N; Keskin O; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Idilman R; Esteban R; Janssen HLA; Berg T; Lampertico P
J Hepatol; 2020 Jun; 72(6):1088-1096. PubMed ID: 31981727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
